Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome.
The aim of the present case-control study was to evaluate the incidence of the (CAG)(n)AR polymorphism in Slovene polycystic ovary syndrome (PCOS) patients. The polymorphism was not found to be a major risk factor for the presence of PCOS and for hyperandrogenemia in PCOS.
Ferk
Polonca
P
Department of Obstetrics and Gynecology, Division of Medical Genetics, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Perme
Maja Pohar
MP
Teran
Natasa
N
Gersak
Ksenija
K
D015897:Comorbidity; D005260:Female; D020022:Genetic Predisposition to Disease / Q000453:epidemiology* / Q000235:genetics*; D006801:Humans; D017588:Hyperandrogenism / Q000453:epidemiology* / Q000235:genetics*; D011085:Polycystic Ovary Syndrome / Q000453:epidemiology* / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D015995:Prevalence; D011944:Receptors, Androgen / Q000235:genetics*; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D017524:Slovenia / Q000453:epidemiology
D011944:Receptors, Androgen